White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, LeRoy EC, Mitrane MP, Paulus HE, Postlethwaite AE, Steen VD 1995 Guidelines for clinical trials in systemic sclerosis (scleroderma): I. Disease-modifying interventions. Arthritis Rheum 38:351-360....
Treatment of interstitial lung disease in systemic sclerosis: guidelines and new clinical trial results Interstitial lung disease (ILD) is the leading cause of death in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). The Ameri... SR Johnson,EJ Bernstein - 《Current ...
Recent European guidelines have introduced the concept of exercise pulmonary hypertension (ex-PH). However, the clinical characteristics of ex-PH in systemic sclerosis (SSc) remains unknown. We aimed to investigate the characteristics of exercise pulmona
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 months. Once the leadin
To investigate the potential contribution of chest wall muscle area (CWMA) to the ventilatory efficiency and exercise capacity in patients with Systemic Sclerosis (SSc) without interstitial lung disease (ILD). Forty-four consecutive SSc patients [F = 37, median age 53.5 years (IQR 43.5–58)...
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ involvement, fibrosis and vasculopathy. Treatment in SSc, including early diffuse cutaneous SSc (dcSSc) and the use of organ-specific therapies, has improved, as evi
Some further information has been published since the guidelines dissemination. This applies to: Lack of efficacy tests does not imply that How I treat SSc: the experts' opinion-the Padua Experience The therapeutic approach to patients with systemic sclerosis (SSc) should be tailored to their ...
Environmental factors in autoimmune diseases and their role in multiple sclerosis Cell. Mol. Life Sci., 73 (2016), pp. 4611-4622, 10.1007/s00018-016-2311-1 View in ScopusGoogle Scholar [2] F. Assan, R. Seror, X. Mariette, G. Nocturne New 2019 SLE EULAR/ACR classification criteria are...
Systemic sclerosis (SSc; also known as “scleroderma”) is an autoimmune disorder characterized by extensive fibrosis, vascular changes, and immunologic dysregulation. Baicalein (phenolic flavonoid derived from Scutellaria baicalensis Georgi) has been us
Systemic Sclerosis (SSc) is a disease with limited therapeutic possibilities. Mesenchymal stem cells (MSCs)-therapy could be a promising therapeutic option, however the ideal MSCs source has not yet been found. To address this problem, we perform compari